VYNE stock

Vyne Therapeutics Inc (VYNE) valuation · rev $570.0K

Vyne Therapeutics Inc (VYNE) rev $570.0K.

Cached valuation scalars
MetricValue
Market cap$21.1M
Revenue$570.0K
P/S37.0
P/B0.9
These valuation metrics as JSON? API free 100/day

VYNE valuation FAQ

What is VYNE's market cap?

Vyne Therapeutics Inc (VYNE) market cap is $21.1M on the latest cached fundamentals snapshot.

What is VYNE's latest revenue?

Latest cached Vyne Therapeutics Inc (VYNE) revenue was $570.0K. Statements: https://lician.com/financials/vyne

What is VYNE's price-to-sales ratio?

Vyne Therapeutics Inc (VYNE) price-to-sales (P/S) is 37.0, cached market cap $21.1M divided by revenue $570.0K.

What is VYNE's price-to-book ratio?

Vyne Therapeutics Inc (VYNE) price-to-book (P/B) is 0.9 on the latest cached fundamentals snapshot.

How many VYNE valuation scalars are listed on this page?

This page lists 4 cached valuation scalars for Vyne Therapeutics Inc (VYNE): Market cap, Revenue, P/S, and P/B.

Where is VYNE valuation listed?

Cached valuation multiples for Vyne Therapeutics Inc (VYNE) are listed at https://lician.com/valuation/vyne.

Not investment advice. Cached rows, not a live tape.